BCL7C polyclonal (N-term), anti-human
€0.00
In stock
SKU
AC-AP18065a
Catalog Number: AC-AP18065a
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB37588
Applications: WB
Datasheet
Request Information
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB37588
Applications: WB
Datasheet
Request Information
Background:
This gene is identified by the similarity of its product to the N-terminal region of BCL7A protein. The BCL7A protein is encoded by the gene known to be directly involved in a three-way gene translocation in a Burkitt lymphoma cell line. The function of this gene has not yet been determined.
Other Names:
B-cell CLL/lymphoma 7 protein family member C, BCL7C
Target/Specificity:
This BCL7C antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 8-34 amino acids from the N-terminal region of human BCL7C.
Antigen Region:
8-34
Antigen Type: Synthetic Peptide
Gene Name: BCL7C
Gene ID: 9274
Primary Accession: Q8WUZ0
NCBI Accession: NP_004756.2
Other Accession: O08664; NP_004756.2
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
This gene is identified by the similarity of its product to the N-terminal region of BCL7A protein. The BCL7A protein is encoded by the gene known to be directly involved in a three-way gene translocation in a Burkitt lymphoma cell line. The function of this gene has not yet been determined.
Other Names:
B-cell CLL/lymphoma 7 protein family member C, BCL7C
Target/Specificity:
This BCL7C antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 8-34 amino acids from the N-terminal region of human BCL7C.
Antigen Region:
8-34
Antigen Type: Synthetic Peptide
Gene Name: BCL7C
Gene ID: 9274
Primary Accession: Q8WUZ0
NCBI Accession: NP_004756.2
Other Accession: O08664; NP_004756.2
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
| Is Featured? | No |
|---|
Write Your Own Review